They are not intended to represent clinical evidence in humans, and BPC-157 has not been approved by the FDA, EMA, or any other regulatory authority for any indication
Peptide therapy handbook for healthcare professionals: Thymosin beta 4
While BPC-157 and TB-500 rebuild tissue, KPV manages inflammation and GHK-Cu supports skin and connective tissue, creating a complete healing environment
BPC-157 peptides are synthetic research compounds based on a 15-amino-acid sequence derived from gastric juice protein
The peptide is not approved by Health Canada for any therapeutic use, meaning licensed physicians cannot prescribe it and pharmacies cannot dispense it
In Australia , BPC157 is considered a prescription-only substance and cannot be legally imported or used without special approval